首页> 外文会议>MRS fall meeting >Nano-Surface Modification on Titanium Implants for Drug Delivery
【24h】

Nano-Surface Modification on Titanium Implants for Drug Delivery

机译:钛植入物的纳米表面修饰用于药物递送

获取原文

摘要

The surface layer of titanium implants, i.e. titanium dioxide, is responsible for the inertness of titanium-based implants within the human body. However, their cytocompatibility properties and long-term efficacy are limited without further surface engineering since the average functional lifetime of an orthopedic implant is only 10 to 15 years. In this study, an electrochemical method known as anodization was used to create titania nanotubular structures on titanium implant surfaces. These nanotubes were about 60 nm wide (inner diameter) and 200 nm deep. In vitro studies found that anodized surfaces consisting of titania nanotube arrays were favored by bone-forming cells (osteoblasts) compared to unanodized surfaces. These titania nano-tubular structures were utilized here as novel drug release delivery systems. It is proposed that the system designed here can have multi-functional drug release to inhibit infection and wound inflammation while increasing new bone formation. For this purpose, antibiotic drugs (penicillin and streptomycin) were loaded into these nanotubular structures by physical adsorption. To mediate interactions between drug molecules and nanotube walls, anodized titanium nanotubes were modified by silanization to possess amine or methyl groups on their surface instead of -OH groups. Results showed increased hydrophobicity of chemically modified titania nanotubes (methyl > amine > hydroxyl terminated surface). These drug loaded substrates were soaked in phosphate buffered solution in a simulated body environment to determine drug release behavior. Buffer solutions were collected and replaced every day. The eluted drug amounts were measured spectroscopically. Results showed more antibiotic penicillin and streptomycin released from chemically modified nanotubes compared to unanodized titanium substrates; specifically, titania anodized nanotubes functionalized with -OH groups did quite well. In this manner, this study advances titanium currently used in orthopedics to possess drug release behavior which can improve orthopedic implant efficacy.
机译:钛植入物的表面层,即二氧化钛,负责人体中钛基植入物的惰性。但是,由于整形外科植入物的平均功能寿命只有10到15年,因此它们的细胞相容性和长期疗效在没有进一步的表面工程设计的情况下就受到了限制。在这项研究中,一种称为阳极氧化的电化学方法被用来在钛植入物表面上创建二氧化钛纳米管结构。这些纳米管的宽度约为60 nm(内径),深度约为200 nm。体外研究发现,与未阳极氧化的表面相比,由二氧化钛纳米管阵列组成的阳极氧化表面更受成骨细胞(成骨细胞)的青睐。这些二氧化钛纳米管结构在这里用作新型药物释放递送系统。建议在此设计的系统可以具有多功能的药物释放功能,以抑制感染和伤口发炎,同时增加新的骨骼形成。为此,通过物理吸附将抗生素药物(青霉素和链霉素)加载到这些纳米管结构中。为了介导药物分子与纳米管壁之间的相互作用,阳极氧化的钛纳米管通过硅烷化改性,使其表面上具有胺或甲基而不是-OH。结果显示化学修饰的二氧化钛纳米管的疏水性增加(甲基>胺>羟基封端的表面)。将这些载有药物的底物在模拟的人体环境中浸泡在磷酸盐缓冲液中,以确定药物的释放行为。每天收集并更换缓冲溶液。用光谱法测量洗脱的药物量。结果表明,与未经阳极氧化的钛底物相比,从化学修饰的纳米管中释放出的抗生素青霉素和链霉素更多;特别地,用-OH基团官能化的二氧化钛阳极氧化的纳米管效果很好。通过这种方式,这项研究使目前在整形外科中使用的钛具有能够改善整形外科植入物功效的药物释放行为。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号